CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Treasury Stock	Accumulated Other Comprehensive Income	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2018			58,491,281		1,311,880
Beginning balance at Dec. 31, 2018	$ 57,118	$ 2,596	$ 6	$ 80,146	$ (5,832)	$ 0	$ (17,202)	$ 2,596
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock-based awards (in shares)	2,590,274		342,139		1,244,725
Exercise of stock-based awards	$ 3,225			(4,299)	$ 7,524
Exercise of warrants (in shares)	190,575		3,229,295		46,409
Exercise of warrants	$ 3,392			3,165	$ 227
Stock-based compensation	2,236			2,236
Contributed capital, professional service fees paid by shareholder	2,891			2,891
Shares exchanged for withholding on stock options and shares repurchased (in shares)					(906,128)
Shares exchanged for withholding on stock options and shares repurchased	(9,331)				$ (9,331)
Net equity deficit from reverse recapitalization (in shares)			14,574,755		926,874
Net equity deficit from reverse recapitalization	(68,373)		$ 2	(75,787)	$ 7,412
Unrealized gain on investment in convertible notes	0
Net income (loss)	(36,764)						(36,764)
Ending balance (in shares) at Dec. 31, 2019			76,637,470		0
Ending balance at Dec. 31, 2019	(43,010)		$ 8	8,352	$ 0	0	(51,370)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class A-2 Common Stock to Class A-1 Common Stock (in shares)			1,666,636
Conversion of Class A-2 Common Stock to Class A-1 Common Stock	$ 19,924			19,924
Exercise of stock-based awards (in shares)	359,987		359,987
Exercise of stock-based awards	$ 839			839
Exercise of warrants (in shares)			510
Exercise of warrants	4			4
Stock-based compensation	5,538			5,538
Exchange of warrants for common stock (in shares)			5,581,890
Exchange of warrants for common stock	54,471			54,471
Issuance of common stock, net (in shares)			9,133,015
Issuance of common stock, net	90,422		$ 1	90,421
Unrealized gain on investment in convertible notes	93					93
Net income (loss)	(410)						(410)
Ending balance (in shares) at Dec. 31, 2020			93,379,508		0
Ending balance at Dec. 31, 2020	$ 127,871		$ 9	179,549	$ 0	93	(51,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock-based awards (in shares)	577,719		732,360
Exercise of stock-based awards	$ 1,704			1,704
Stock-based compensation	$ 6,403			6,403
Repurchase of common stock (in shares)	(701,305)		(701,305)		(701,305)
Repurchase of common stock	$ (8,983)				$ (8,983)
Unrealized gain on investment in convertible notes	(93)					(93)
Net income (loss)	31,559						31,559
Ending balance (in shares) at Dec. 31, 2021			93,410,563		701,305
Ending balance at Dec. 31, 2021	$ 158,461		$ 9	$ 187,656	$ (8,983)	$ 0	$ (20,221)